Cite Filings / DNLI / 0001714899-21-000034
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
S-8

Securities Offered to Employees in Benefit Plans

Denali Therapeutics Inc. · Filed 2021-02-26 · Acc 0001714899-21-000034

Documents 1

  • S-8 Securities Offered to Employees in Benefit Plans , forms-82021.htm

Around this filing

  • 2022-02-28 S-8 Securities Offered to Employees in Benefit Plans
  • 2021-03-03 4 Director sold 100,000 shares at an average $66.22 ($6,622,207)
  • 2021-03-03 4 President and CEO sold 18,334 shares at an average $66.35 ($1,216,551)
  • 2021-02-26 S-8 Securities Offered to Employees in Benefit Plans
  • 2021-02-26 10-K Annual Report
  • 2021-02-25 8-K Results of operations
  • 2020-02-28 S-8 Securities Offered to Employees in Benefit Plans

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading forms-82021.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…